Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
OVID · Dec 31, 2025
Ovid Therapeutics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-26-019438General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-528.60% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
1181.27% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-585.20% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
352.76% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
66.29% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20255/6 normalizedLevel 3Jun 30, 20255/6 normalizedLevel 3Sep 30, 20255/6 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- -9751.52%
- Current
- -528.60%
- Delta
- 9222.92%
- Previous
- -23.70%
- Current
- 1181.27%
- Delta
- 1204.97%
- Previous
- -9487.12%
- Current
- -585.20%
- Delta
- 8901.92%
- Previous
- 4446.97%
- Current
- 352.76%
- Delta
- -4094.21%
- Previous
- 839.39%
- Current
- 66.29%
- Delta
- -773.11%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Has State · Ovid Therapeutics Inc. →Transitioned To · OVID Fundamental State →Transitioned To · OVID CASH_GENERATION_INCREASED →Transitioned To · OVID GROWTH_INCREASED →Transitioned To · OVID PROFITABILITY_INCREASED →Transitioned To · OVID R_AND_D_INTENSITY_DECREASED →Transitioned To · OVID SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.